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Abstract: Chemical investigation of the Dongsha Atoll soft coral Lobophytum crassum has 
afforded four new cembranoids, crassumols A–C (1–3) and 13-acetoxysarcophytoxide (4). 
The structures of these isolated compounds were elucidated by extensive NMR and 
HRESIMS experiments. The cytotoxicity and anti-HCMV (Human cytomegalovirus) 
activities of 1–4 were evaluated in vitro. Compound 4 exhibited cytotoxicity against A-549 
(human lung carcinoma) cell line with an ED50 of 3.6 μg/mL. 
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1. Introduction 
Soft corals belonging to the genus Lobophytum (Alcyoniidae) have been well recognized as a rich 
source of secondary metabolites endowed with a range of structural diversity and various biological 
activities [1–21]. Previous bioassay results of some cembraniods and their analogues have demonstrated 
remarkable pharmacological potential such as in vitro cytotoxicity against various cancer cell lines [2–9], 
anti-inflammatory properties [10–12], antimicrobial activities [10], and HIV-inhibitory activity [13].   
In view of their scientific significance and potential usage, we have investigated the Dongsha Atoll  
soft coral Lobophytum crassum (Von Marenzeller, 1886) (Figure 1) for the bioactive substances. Four 
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new cembranoids, crassumols A–C (1–3) and 13-acetoxysarcophytoxide (4) were isolated from the 
acetone-soluble of Dongsha Atoll collection of L. crassum. 
Figure 1. Soft coral Lobophytum crassum. 
 
2. Results and Discussion 
Specimens of L. crassum were frozen immediately after collection. Conventional extraction procedures 
were used, and the acetone extract was exhaustively partitioned between EtOAc and H2O to afford the 
EtOAc-soluble fraction, which was evaporated under vacuum to yield a dark brown gum (20 g). The 
resultant concentrated residue was subsequently subjected to fractionation with column chromatography 
and high-performance liquid chromatography, leading to the isolation of four new cembranoids, 
crassumols A–C (1–3) and 13-acetoxysarcophytoxide (4) (Figure 2).  
Figure 2. The structures of compounds 1–4. 
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Crassumol A (1) appeared as colorless oil. Its HRESIMS (m/z 345.2408, [M + Na]
+) and NMR 
spectroscopic data (Tables 1 and 2) established the molecular formula C20H34O3, implying the existence 
of four degrees of unsaturation. Three tertiary hydroxyls were recognized as being present in 1 from its 
13C NMR signals at δC 81.5 (qC, C-1), 73.7 (qC, C-4), and 75.1 (qC, C-15) and 
1H NMR signals at  
δH 2.52 (1H, s, OH-1), 3.58 (1H, s, OH-4), and 3.03 (1H, s, OH-15) as well as from a broad IR 
absorption at 3421 cm
−1. Moreover, the 
13C NMR signals at δC 128.3 (CH, C-2), 139.1 (CH, C-3), 
129.0 (CH, C-7), 133.2 (qC, C-8), 126.3 (CH, C-11), and 137.0 (qC, C-12), assigned one disubstituted 
double bond and two trisubstituted double bonds in 1. The above functionalities also account for three Mar. Drugs 2011, 9  
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of the four degrees of unsaturation, suggesting a monocyclic structure in 1. By interpretation of   
1H–
1H COSY correlations, it was possible to establish four partial structures from H-2 to H-3, from H2-5 
to H-7, from H-9 to H-11, and from H-13 to H-14 (Figure 3). Moreover, the connectivities of these 
partial structures through the quaternary carbons were further established by the HMBC correlations 
(Figure 3). Thus, the gross structure of crassumol A was assigned as 1. The relative configurations of 1 
were assigned by NOESY correlations (Figure 4) between H-3/Me-18, H-3/OH-1, H-3/H-7, H-2/OH-4, 
H-2/H-13a, H-11/H-13a, and Me-19/H-11. On the basis of the aforementioned observations,   
the structure of crassumol A (1) was unambiguously established as (1S*,4S*,2E,7E,11E)-1,4, 
15-trihydroxycembra-2,7,11-trien. 
Table 1. 
1H NMR data 
a for compounds 1–4. 
 1  2  3  4 
2 5.79  d  (15.6) 
b  5.51 d (9.6)  5.53 d (10.4)  5.60 d (11.8) 
3 5.92  d  (15.6)
  5.59 d (9.6)
  5.03 d (10.4)
  5.23 d (11.8)
 
5a  1.94 ddd (13.2, 8.0, 2.0)  2.48 m   2.15 m  2.34 m 
5b  1.67 m  2.30 m  1.93 m   2.36 m 
6a  1.67 m  2.42 m  1.92 m  2.96 m  
6b  2.27 m  1.84 m   1.82 m  1.63 m 
7  5.32 t (8.0)  3.53 dd (10.8, 2.8)  5.04 d (10.0)  2.59 t (4.0) 
9a  2.13 m  2.16 m   1.87 m  2.15 ddd (13.2, 4.8, 2.8) 
9b  1.97 m   2.00 m  1.60 m   0.92 td (13.2, 3.2) 
10a  2.06 m  2.20 m   2.23 m  2.27 m 
10b  2.08 m  1.78 m  2.06 m   1.92 m 
11  5.22 dd (9.4, 4.8)  3.74 d (12.0)  4.89 br d (8.0)  5.41 d (10.8, 5.2) 
13a  2.22 m   2.22 m  1.97 m   5.16 d (9.2) 
13b  2.07 m  1.78 m   1.87 m   
14a  2.12 m   2.64 dt (13.2, 9.8)  2.57 ddd (14.0, 11.6, 8.0) 2.75 dd (14.8, 10.4) 
14b  1.71 m  2.07 m  2.14 m   1.87 m 
16  1.07 s  4.57 dq (15.2, 4.8)  4.48 m  4.49 br s 
17  1.12 s  1.59 s  1.65 s  1.66 s 
18  1.25 s  1.82 s  1.87 s  1.91 s 
19  1.59 s  1.45 s  1.09 s  1.28 s 
20  1.64 s  1.48 s  1.65 s  1.61 s 
OH-1 2.52  s      
OH-4 3.58  s      
OH-15 3.03  s      
OAc     2.11 s  2.00 s 
a Spectra were measured in CDCl3 (400 MHz); 
b J values (in Hz) in parentheses. 
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Table 2. 
13C NMR data 
a of compounds 1–4. 
 1  2  3 4  
1 81.5  (qC) 
b  126.8 (qC)  134.1 (qC)  130.8 (qC) 
2  128.3 (CH)  85.1 (CH)  83.8 (CH)  83.3 (CH) 
3  139.1 (CH)  126.7 (CH)  127.6 (CH)  126.1 (CH) 
4  73.7 (qC)  137.6 (qC)  137.9 (qC)  140.2 (qC) 
5 45.3  (CH2) 35.8  (CH2) 35.6  (CH2) 37.7  (CH2) 
6 24.1  (CH2) 24.2  (CH2) 24.8  (CH2) 25.1  (CH2) 
7  129.0 (CH)  83.7 (CH)  77.3 (CH)  61.7 (CH) 
8  133.2 (qC)  68.3 (qC)  75.3 (qC)  59.5 (qC) 
9 39.9  (CH2) 40.9  (CH2) 37.4  (CH2) 39.7  (CH2) 
10 24.4  (CH2) 23.2  (CH2) 23.7  (CH2) 23.2  (CH2) 
11  126.3 (CH)  80.5 (CH)  123.2 (CH)  127.4 (CH) 
12  137.0 (qC)  71.4 (qC)  137.1 (qC)  134.9 (qC) 
13 36.4  (CH2) 38.9  (CH2) 36.6  (CH2) 76.9  (CH) 
14 30.4  (CH2) 17.8  (CH2) 24.1  (CH2) 31.4  (CH2) 
15  75.1 (qC)  134.6 (qC)  127.3 (qC)  129.9 (qC) 
16 25.1  (CH3) 77.5  (CH2) 78.5  (CH3) 78.3  (CH2) 
17 25.2  (CH3) 9.1  (CH3) 10.3  (CH3) 10.1  (CH3) 
18 28.8  (CH3) 15.1  (CH3) 15.9  (CH3) 15.7  (CH3) 
19 14.9  (CH3) 20.1  (CH3) 24.9  (CH3) 16.7  (CH3) 
20 15.0  (CH3) 23.3  (CH3) 15.1  (CH3) 9.9  (CH3) 
OAc     170.4 (qC)  170.3 (qC) 
    20.9  (CH3) 21.1  (CH3) 
a Spectra were measured in CDCl3 (100 MHz); 
b Multiplicity are deduced by HSQC and DEPT experiments. 
Figure 3. Selected 
1H–
1H COSY (▬) and HMBC (→) correlations of 1 and 2. 
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Figure 4. Selected NOESY correlations of 1. 
18
16
3 17
2
20
4-OH
1-OH
13a
7
19
6b
11
9a
14b
10b
9b
 
The HRESIMS of crassumol B (2) exhibited a pseudo molecular ion peak at m/z, 359.1878 ([M + Na]
+), 
consistent with the molecular formula of C20H32O4, requiring five degrees of unsaturation. Its spectrum 
showed a broad absorption band at 3412 cm
−1 (OH stretching). The 
13C NMR signals at δC 126.8 (qC, 
C-1), 134.6 (qC, C-15), 126.7 (CH, C-3), and 137.6 (qC, C-4) assigned a trisubstituted double bond 
and a tetrasubstituted double bond in 2, respectively. The above functionalities account for two of the 
five degrees of unsaturation, suggesting a tricyclic structure in 2. Two tertiary hydroxyls were present 
in  2 from its 
13C NMR signals at δC  68.3 (qC, C-8) and 71.4 (qC, C-12). The presence of two 
oxygenated methine [δH 3.53 (dd, 1H, J = 10.8, 2.8 Hz) and δC 83.7 (C-7); δH 3.74 (d, 1H, J = 12.0 Hz) 
and δC 80.5 (C-11)] implied that an ether linkage is probably present between C-7 and C-11, which 
was confirmed by the HMBC correlations from H-7 to C-11, and from H-11 to C-7. Correlations 
deduced from extensive analyses of the 
1H–
1H COSY correlations (Figure 3) of 2 enabled initially the 
establishment of four partial structures. The connectivity of the above structural fragments was 
subsequently interconnected by the HMBC correlations (Figure 3). The locations of the two double 
bonds at C-3/C-4 and C-1/C-15 were clarified by analysis of the HMBC correlations from Me-18 to  
C-3, C-4, and C-5, and from Me-17 to C-1, C-15, and C-16. Furthermore, the crucial NOE correlations 
(Figure 5) between H-2/Me-18, H-2/H-14b, H-11/H-7, H-11/H-9b, H-11/H-14b, H-11/H-10a,   
Me-19/H-9a, Me-19/H-10b, and Me-20/H-10b demonstrated the 2S*, 7S*, 8R*, 11S*, and 12R* 
configurations as depicted in Figure 5. Accordingly, the structure of crassumol B (2) was fully 
determined as (2S*,7S*,8R*,11S*,12R*,3E)-8,12-dihydroxy-7,11:2,16-bisepoxycembra-1(15),3-diene. 
Figure 5. Selected NOESY correlations of 2. 
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Crassumol C (3) was isolated as colorless oil. The HRESIMS of 3 exhibited a pseudo molecular ion 
peak at m/z 385.2854 [M + Na]
+, consistent with the molecular formula of C22H34O4, implying the 
existence of six degrees of unsaturation. 
13C NMR signals at δC 134.1 (qC, C-1), 127.3 (qC, C-15), 
127.6 (CH, C-3), 137.9 (qC, C-4), 123.2 (CH, C-11), and 137.1 (qC, C-12) assigned a tetrasubstituted 
double bond and two trisubstituted double bonds in 3, respectively. An acetoxymethine was present in 3 
from its 
1H NMR signals at δH 5.04 (1H, d, J = 10.0 Hz), 2.11 (3H, s) and 
13C NMR signals at δC 77.3 
(CH, C-7), 20.9 (CH3) and 170.4 (qC). The above functionalities account for four of the six degrees  
of unsaturation, suggesting a bicyclic structure in 3. By interpretation of 
1H–
1H COSY correlations 
(Figure 6), it was possible to establish four partial structures of consecutive proton systems extending 
from H-2 to H-3, from H2-5 to H2-7 through H2-6, from H2-9 to H-11 through H2-10, and from H-13  
to H2-14, as well as long-range COSY correlations between H-2/H2-14, H-2/H2-16, Me-18/H-3, and 
Me-17/H2-16. The long-range COSY correlations between H-2/H2-16 and Me-17/H2-16 also exhibited 
the presence of a 2,5-dihydrofuran ring in 3. Subsequently, the connectivities of these partial structures 
were further established by the HMBC correlations (Figure 3). Thus, the gross structure of crassumol C 
was assigned as 3. The relative stereochemistry of 3 was assigned by NOESY correlations (Figure 7). 
NOE correlations between H-2/Me-18, Me-18/H-11, Me-18/H-5b, H-5a/H-3, H-11/H-7, H-14a/Me-17, 
H-14a/H-13a, H-13b/H-11, H-10a/Me-20, H-10a/Me-19 demonstrated the 2S*, 7S*, and 8S* 
configurations of 3. On the basis of the aforementioned observations, the structure of crassumol C (3) 
was unambiguously established as (2S*,7S*,8S*,3E,11E)-7-acetoxy-8-hydroxycembra-3,11-dien. 
Figure 6. Selected 
1H–
1H COSY (▬) and HMBC (→) correlations of 3 and 4. 
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The HRESIMS of 13-acetoxysarcophytoxide (4) exhibited a pseudo molecular ion peak at m/z 
383.2196 [M + Na]
+, consistent with the molecular formula of C22H32O4, requiring seven degrees of 
unsaturation. A trisubstituted epoxide was recognized as being present in 4 from its 
1H NMR signals at 
δH 2.59 (1H, t, J = 4.0 Hz) and 
13C NMR signals at δC 59.5 (qC, C-8) and 61.7 (CH, C-7). Moreover, 
the 
13C NMR signals at δC 130.8 (qC, C-1), 129.9 (qC, C-15), 126.1 (CH, C-3), 140.2 (qC, C-4), 127.4 
(CH, C-11), and 134.9 (qC, C-12) assigned a tetrasubstituted double bond and two trisubstituted 
double bonds in 3, respectively. An acetoxymethine was present in 4 from its 
1H NMR signals at  
δH 5.16 (1H, d, J = 9.2 Hz), 2.00 (3H, s) and 
13C NMR signals at δC 76.9 (CH, C-13), 21.1(CH3) and 
170.3 (qC). The above functionalities account for five of the seven degrees of unsaturation, suggesting 
a tricyclic structure in 4. By interpretation of 
1H–
1H COSY correlations (Figure 6), it was possible to 
establish four partial structures of consecutive proton systems extending from H-2 to H-3, from H2-5 to 
H2-7 through H2-6, from H2-9 to H-11 through H2-10, and from H-13 to H2-14, as well as long-range 
COSY correlations between H-2/H2-14, H-2/H2-16, Me-18/H-3, and Me-17/H2-16. The long-range COSY 
correlations between H-2/H2-16 and Me-17/H2-16 also exhibited the presence of a 2,5-dihydrofuran 
ring in 4. Subsequently, the connectivities of these partial structures were further established by the 
HMBC correlations (Figure 6). The relative configurations of 4 were determined by NOE correlations 
(Figure 8) between H-2/Me-18, H-13/H-2, H-13/H-11, H-11/H-7, H-14a/Me-17, H-14a/Me-20, H-10a/ 
Me-20, H-10a/H-9a, Me-18/Me-19, H-11/Me-18. On the basis of the aforementioned observations, the 
structure of 4 was unambiguously established as (2S*,7S*,8S*,13S*,3E,11E)-13-acetoxy-7,8-epoxy 
cembra-3,11-dien. 
Figure 8. Selected NOESY correlations of 4. 
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The cytotoxicity against P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma), 
and A-549 (human lung epithelial carcinoma) tumor cells of 1–4 are shown in Table 3. Compounds 1–4 
did not show anti-HCMV activity.  
It is possible that compound 2 arise from the precursor with a 7,8-epoxide. Transannular opening of 
the 7,8-epoxide by an 11-hydroxyl would give rise to an oxepane ring in compounds 2 as shown in 
Figure 9. The major metabolite, (+)-sarcophytoxide (5), should be the precursor for compounds 2–4. 
Therefore, the absolute configuration at C-2 for compounds 2–4 should be S. 
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Table 3. Cytotoxicity 
a of 1–4. 
Compounds 
Cell lines ED50 (µg/mL) 
A549 HT-29  P-388 
1  >50 >50  >50 
2  >50 >50  >50 
3  >50 >50  >50 
4  3.6 10  28 
mithramycin 
b 0.18  0.21  0.15 
a For significant activity of pure compounds, an ED50 of ≤4.0 µg/mL is required; 
b Positive control. 
Figure 9. Plausible biosynthetic pathway to compounds 2–4. 
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3. Experimental Section  
3.1. General Experimental Procedures 
Optical rotations were determined with a JASCO P1020 digital polarimeter. Ultraviolet (UV) and 
infrared (IR) spectra were obtained on a JASCO V-650 and JASCO FT/IR-4100 spectrophotometers, 
respectively. The NMR spectra were recorded on a Varian MR 400 NMR spectrometer at 400 MHz for 
1H and 100 MHz for 
13C or on a Varian Unity INOVA 500 FT-NMR spectrometer at 500 MHz for  
1H and 125 MHz for 
13C, respectively. Chemical shifts are expressed in δ (ppm) referring to the solvent 
peaks δH 7.27 and δC 77.0 for CDCl3, respectively, and coupling constants are expressed in Hz. ESI-MS 
were recorded by ESI FT-MS on a Bruker APEX II mass spectrometer. Silica gel 60 (Merck, Germany, 
230–400 mesh) and LiChroprep RP-18 (Merck, 40–63 μm) were used for column chromatography. 
Precoated silica gel plates (Merck, Kieselgel 60 F254, 0.25 mm) and precoated RP-18 F254s plates (Merck) 
were used for thin-layer chromatography (TLC) analysis. High-performance liquid chromatography 
(HPLC) was carried out using a Hitachi L-7100 pump equipped with a Hitachi L-7400 UV detector at 
220 nm together with a semi-preparative reversed-phase column (Merck, Hibar LiChrospher RP-18e,  
5 μm, 250 × 25 mm). Mar. Drugs 2011, 9  
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3.2. Biological Material  
The soft coral L. crassum was collected by hand using SCUBA along the coast reefs offshore from 
the Dongsha Atoll in April 2007, at a depth of 6 m, and was stored in a freezer for 14 months until 
extraction. Identification was kindly verified by Prof. Chang-Feng Dai, Institute of Oceanography, 
National Taiwan University, Taiwan. A voucher specimen (TS-11) was deposited in the Department of 
Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan. 
3.3. Extraction and Isolation  
The frozen soft coral (2.2 kg) was chopped into small pieces and extracted exhaustively  by 
maceration with fresh acetone for 24 h at room temperature. The quantity of solvent used for each 
extraction (2 L) was at least three times the amount of the soft coral material used. The acetone 
extracts were filtered and concentrated under vacuum to yield a brownish oily residue, which was 
subsequently partitioned between EtOAc and H2O. The resulting EtOAc-soluble residue (20.1 g) was 
subjected to silica gel 60 column chromatography (Si 60 CC) using hexane–EtOAc and EtOAc–MeOH 
of increasing polarity for elution to give roughly 40 fractions on the basis of the 
1H NMR spectroscopic 
data and TLC analyses. Fraction 16 (2.0 g) eluted with n-hexane–EtOAc (1:2) was subjected to Si 60 CC 
(n-hexane–EtOAc, 60:1 to 1:3) to furnish 9 subfractions. A subfraction 16-4 (0.57 g) eluted with   
n-hexane–EtOAc (1:2) was subjected to a RP-18 flash column (MeOH–H2O, 52:48 to 100:0) to give 
six subfractions. In turn, a subfraction 16-4-1 (38 mg) eluted with MeOH–H2O (70:30) was further 
purified by RP-18 HPLC using MeOH–H2O (68:32) to give 4 (4.2 mg). Fraction 18 (2.2 g) eluted  
with  n-hexane–EtOAc (1:6) was subjected to Si 60 CC (n-hexane–EtOAc, 20:1 to 1:3) to furnish 
4 subfractions. A subfraction 18-4 (0.28 g) eluted with n-hexane–EtOAc (1:3) was fractionated by a 
RP-18 flash column (MeOH–H2O, 53:47 to 100:0) to give six subfractions. In turn, a subfraction 18-4-4 
(35 mg) eluted with MeOH–H2O (80:20) was further purified by RP-18 HPLC using MeOH–H2O 
(80:20) to give 1 (3.0 mg). Subfraction 18-2 (0.11 g) eluted with n-hexane–EtOAc (1:1) was fractionated 
by a RP-18 flash column (MeOH–H2O, 53:47 to 100:0) to give six subfractions. In turn, a subfraction 
18-2-1 (35 mg) eluted with MeOH–H2O (70:30) was further purified by RP-18 HPLC using   
MeOH–H2O (65:35) to give 3 (3.0 mg). Fraction 20 (0.23 g) eluted with n-hexane–EtOAc (1:10) was 
subjected to Si 60 CC (n-hexane–EtOAc, 1:1 to 1:10) to furnish 10 subfractions. A subfraction 20-2 
(40 mg) eluted with n-hexane–EtOAc (1:8) was further purified by RP-18 HPLC using MeOH–H2O 
(65:35) to give 2 (2.1 mg). 
Crassumol A (1): Colorless oil; [α]
25
D −20 (c 0.1, CHCl3); IR (neat) νmax 3421, 2972, 2928, 2851, 
1576, 1446, 1396, 1119, 1075 cm
−1; 
1H NMR (CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) 
data in Tables 1 and 2; HRESIMS m/z 345.2408, [M + Na]
+ (Calcd for C20H34O3Na, 345.2406). 
Crassumol B (2): Colorless oil; [α]
25
D −40 (c 0.1, CHCl3); IR (neat) νmax 3412, 2933, 2857, 1546, 
1444, 1379, 1128, 1007, 1032, 941 cm
−1; 
1H NMR (CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) 
data in Tables 1 and 2; HRESIMS m/z 359.1878 [M + Na]
+ (Calcd for C20H32O4Na, 359.1876). Mar. Drugs 2011, 9  
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Crassumol C (3): Colorless oil; [α]
25
D −72 (c 0.1, CHCl3); IR (neat) νmax 3447, 2932, 2858, 1732, 
1447, 1373, 1242, 1034 cm
−1; 
1H NMR (CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) data in 
Tables 1 and 2; HRESIMS m/z 385.2854 [M + Na]
+ (Calcd for C22H34O4Na, 385.2855). 
13-Acetoxysarcophytoxide (4): Colorless oil; [α]
25
D +14 (c 0.1, CHCl3); IR (neat) νmax 2939, 2858, 
1733, 1663, 1446, 1373, 1237, 1042 cm
−1; 
1H NMR (CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) 
data in Tables 1 and 2; HRESIMS m/z 383.2196 [M + Na]
+ (Calcd for C22H32O4Na, 383.2198). 
3.4. Cytotoxicity Assay  
Cytotoxicity was determined on P-388 (mouse lymphocytic leukemia), HT-29 (human colon 
adenocarcinoma), and A-549 (human lung epithelial carcinoma) tumor cells using a modification of 
the MTT colorimetric method according to a previously described procedure [11,22,23]. P-388 cell 
line was kindly supplied by J. M. Pezzuto, formerly of the Department of Medicinal Chemistry and 
Pharmacognosy, University of Illinois at Chicago. HT-29 and A-549 cell lines were purchased from 
the American Type Culture Collection. 
3.5. Anti-HCMV Assay 
To determine the effects of natural products upon HCMV cytopathic effect (CPE), confluent human 
embryonic lung (HEL) cells grown in 24-well plates were incubated for 1 h in the presence or absence 
of various concentrations of tested natural products. Then, cells were infected with HCMV at an input 
of 1000 pfu (plaque forming units) per well of 24-well dish. Antiviral activity was expressed as IC50 
(50% inhibitory concentration), or compound concentration required to reduce virus induced CPE by 
50% after 7 days as compared with the untreated control. To monitor the cell growth upon treating 
with natural products, an MTT-colorimetric assay was employed [24]. 
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